Rostec has mastered most of the money on flu vaccines

The largest vaccination in history

In Russia ends with the unprecedented scale of the program vaccination against influenza. Most regions are planning to complete to vaccinate until the beginning of November, said the Ministry of health (minsa).

For the purchase of influenza vaccines this year, the state spent more than 4 billion rubles, said the Department. This is about 20% more than the amount last year, which said the Agency, amounted to 3.4 billion rubles.

The growth in procurement is due to higher requirements to the organizers of the immunization programme, the coverage rate vaccinated compared to last year rose 40%, indicated in the decision of Rospotrebnadzor “On measures for the prevention of influenza and acute respiratory viral infection epidemic season the period of 2016-2017 years.”

The reason for the increase in the flu epidemic that struck in early 2016 74 regions of Russia. In the past year, the authorities instilled in 31.3% of citizens by setting, according to the Rospotrebnadzor, the record over the years of vaccination, but was unable to prevent the spread of the epidemic.

By the end of October this year in Russia from flu were vaccinated about 40 million people (27.3 per cent of the population), reported in a press-service of Rospotrebnadzor. Of these, 3.8 million people were vaccinated at the expense of regional budgets and programmes of employers. Estimated immunization coverage in 2016 will reach 50 million people, suggested in the CPS.

Who earned vaccination

The purchase of vaccines for state needs in 2016, was engaged in a subsidiary of the state Corporation “rostec” “national immunobiological company” (“national immunobiological company”), the company said. In the middle of 2015, the company was appointed by the government the only supplier of domestic vaccines under the immunization calendar in mid-2015.

So the national vaccination calendar

Free flu vaccines under the national immunization calendar are procured at the Federal level, and is intended only for certain categories of the population. These include children, students, health workers, transport, education, utilities, as well as pregnant and people with certain chronic diseases and people older than 60 years and military service. Among these groups, the MoH and the CPS aim to vaccinate 75% of the population, said chief infectionist of the Ministry Irina Shestakova. These citizens can, ill, to facilitate the occurrence of the epidemic and that among them is usually seen examples of severe disease, she explains. The amount of vaccines being formed by the subjects independently, and then later transferred to the Federal level.

For flu shots in 2016, “national immunobiological company” has spent 4.2 billion rubles, the company said. For the money, “national immunobiological company” has bought 47.8 million doses of vaccines. Of these, 30.1 million doses intended for adults and 17.7 for children. For adults “national immunobiological company”, according to her own information, purchased 20.5 million doses “Savegraph” and 9.6 million doses “Grippola”. For children – 6.4 million doses “Savegraph”, 8.5 million “Grippol plus” and 2.8 million doses of “Ultrix”. All vaccines will be delivered to the regions until 30 October 2016, stressed in the “national immunobiological company”.

The vast majority of the vaccine itself “national immunobiological company” and manufactures. “Savegrp” is produced by FSUE NPO “Microgen”, which should be corporatized and transferred to the management of “national immunobiological company” to the end of the year, and at OOO “FORT”. According to SPARK Interfax, “national immunobiological company” owned by its blocking stake “Fort” (25%+ 1 share), the remaining 75% of the company OOO”, Megard Groups” is controlled by Anton Katlinsky. Also on the capacity of the “FORT” produced vaccine”, Ultrex”.

“Grippol” and “Grippol plus” manufactured by companies that are not affiliated with the “national immunobiological company” Saint — Petersburg research Institute of Vaccines and Sera and pharmaceutical company “Petrovax farm” respectively.

Margin of the company from a single supplier — 34 million rubles., have disclosed in “national immunobiological company”. Another 2.5 billion roubles was spent on their own “Savegrp and “Ultrix” and somehow returned in the structure “national immunobiological company”. “Buying drugs “Microgen” or the “Fort”, we will pay the cost of the drug specified by the manufacturer. To say that something “comes back” due to the purchases of “private” vaccines incorrect,” insisted in the company.

The emergence of the single buyer may reduce competition in the market, said the General Director of the analytical company DSM Group Sergey shuljak. But, on the other hand, the large volume of purchases, as a rule, lead to savings, experts say. According to the calculations of DSM Group, 47.8 million doses of the claimed vaccine was supposed to take about 6 billion rubles., and not 4.2 billion, which met the “national immunobiological company”. The company recognized that they were able to save market price for the vaccines above.

Vaccination at metro

40% of the population needs to be vaccinated not only the efforts of Federal agencies and regional, said in Rospotrebnadzor. So, the Moscow health Department this year organized the work of the special vehicles in which citizens can take root near the exit of metro stations. By 24 October, they instilled in to 100.9 thousand people, reported the press service of the Department of health.

For vaccination near the metro, the city has allocated 12 vehicles. They work alternately in 24 stations. Their work schedule available on the official portal of the mayor and government of Moscow and the websites of the Department and the Moscow metro. The value of the shares to the Moscow city budget, the press service of the Department did not disclose.

Didn’t tell officials about the cost of purchasing vaccines. The Department said that the city has purchased 1.2 million doses of two vaccines: “Grippol plus” and “Savegrp”. According to the website of public procurement, Moscow has spent on flu vaccines this year, about RUB 202.5 million with a planned budget 111,5 mln. to Finance the purchase of influenza vaccine by 57% at the expense of means of the Federal budget and 43% for the city, reported the press service of the Department for healthcare of Moscow.

City officials purchased 500 thousand doses of “Savegraph” of 81.1 million rubles. the Cost of a pack made 1 621,28 RUB “Grippol plus” cost the city about 121,4 million RUB over 680 thousand doses. The cost per package 177,21 RUB and RUB 188,56 (final price of the second contract is not yet listed on the procurement website).